Exploring the metabolic signaling network of GFPT in cancer

Abstract Metabolic homeostasis is essential for cellular function in living organisms. In cancer cells, metabolic processes are reprogrammed to meet the energy demands and biosynthetic needs for rapid growth. This reprogramming enhances nutrient flux through the glycolytic pathway, supporting ATP pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Chibuzo Sampson, Pengfei Li, Yiqian Wang, Jing Liu, Jing Lv, Tian Xia, Hai-long Piao, Yegang Ma
Format: Article
Language:English
Published: Nature Publishing Group 2025-08-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-025-02687-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849226643292291072
author Chibuzo Sampson
Pengfei Li
Yiqian Wang
Jing Liu
Jing Lv
Tian Xia
Hai-long Piao
Yegang Ma
author_facet Chibuzo Sampson
Pengfei Li
Yiqian Wang
Jing Liu
Jing Lv
Tian Xia
Hai-long Piao
Yegang Ma
author_sort Chibuzo Sampson
collection DOAJ
description Abstract Metabolic homeostasis is essential for cellular function in living organisms. In cancer cells, metabolic processes are reprogrammed to meet the energy demands and biosynthetic needs for rapid growth. This reprogramming enhances nutrient flux through the glycolytic pathway, supporting ATP production and branching into pathways that synthesize macromolecules required for cell proliferation. One critical branching pathway is the hexosamine biosynthesis pathway (HBP), which, driven by metabolic reprogramming, facilitates the synthesis of uridine-5’-diphospho-N-acetylglucosamine (UDP-GlcNAc), a glycosylation substrate. This pathway is regulated by the rate-limiting enzyme glutamine-fructose-6-phosphate transaminase (GFPT), a key controller of cellular UDP-GlcNAc levels and protein glycosylation. Dysregulation of GFPT is linked to metabolic disorders, like in diabetes, and it is also frequently upregulated in cancers. Given that GFPT plays a pivotal role in cancer metabolism, elucidating its regulatory interactions with other metabolic signaling pathways under metabolic stress is crucial to identifying therapeutic vulnerabilities in cancer. This review discusses the interaction network of GFPT with other metabolic pathways, its role in nutrient sensing, and the implications of GFPT deregulation in cancer.
format Article
id doaj-art-5466af166f4e4b4c8d2cef34b1dc9977
institution Kabale University
issn 2058-7716
language English
publishDate 2025-08-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj-art-5466af166f4e4b4c8d2cef34b1dc99772025-08-24T11:08:18ZengNature Publishing GroupCell Death Discovery2058-77162025-08-0111112010.1038/s41420-025-02687-3Exploring the metabolic signaling network of GFPT in cancerChibuzo Sampson0Pengfei Li1Yiqian Wang2Jing Liu3Jing Lv4Tian Xia5Hai-long Piao6Yegang Ma7Department of Thoracic Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and InstituteDepartment of Thoracic Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and InstituteDepartment of Radiotherapy, The First Affiliated Hospital of Dalian Medical UniversityDalian Institute of Chemical Physics, Chinese Academy of SciencesDalian Institute of Chemical Physics, Chinese Academy of SciencesDalian Institute of Chemical Physics, Chinese Academy of SciencesDepartment of Thoracic Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and InstituteDepartment of Thoracic Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and InstituteAbstract Metabolic homeostasis is essential for cellular function in living organisms. In cancer cells, metabolic processes are reprogrammed to meet the energy demands and biosynthetic needs for rapid growth. This reprogramming enhances nutrient flux through the glycolytic pathway, supporting ATP production and branching into pathways that synthesize macromolecules required for cell proliferation. One critical branching pathway is the hexosamine biosynthesis pathway (HBP), which, driven by metabolic reprogramming, facilitates the synthesis of uridine-5’-diphospho-N-acetylglucosamine (UDP-GlcNAc), a glycosylation substrate. This pathway is regulated by the rate-limiting enzyme glutamine-fructose-6-phosphate transaminase (GFPT), a key controller of cellular UDP-GlcNAc levels and protein glycosylation. Dysregulation of GFPT is linked to metabolic disorders, like in diabetes, and it is also frequently upregulated in cancers. Given that GFPT plays a pivotal role in cancer metabolism, elucidating its regulatory interactions with other metabolic signaling pathways under metabolic stress is crucial to identifying therapeutic vulnerabilities in cancer. This review discusses the interaction network of GFPT with other metabolic pathways, its role in nutrient sensing, and the implications of GFPT deregulation in cancer.https://doi.org/10.1038/s41420-025-02687-3
spellingShingle Chibuzo Sampson
Pengfei Li
Yiqian Wang
Jing Liu
Jing Lv
Tian Xia
Hai-long Piao
Yegang Ma
Exploring the metabolic signaling network of GFPT in cancer
Cell Death Discovery
title Exploring the metabolic signaling network of GFPT in cancer
title_full Exploring the metabolic signaling network of GFPT in cancer
title_fullStr Exploring the metabolic signaling network of GFPT in cancer
title_full_unstemmed Exploring the metabolic signaling network of GFPT in cancer
title_short Exploring the metabolic signaling network of GFPT in cancer
title_sort exploring the metabolic signaling network of gfpt in cancer
url https://doi.org/10.1038/s41420-025-02687-3
work_keys_str_mv AT chibuzosampson exploringthemetabolicsignalingnetworkofgfptincancer
AT pengfeili exploringthemetabolicsignalingnetworkofgfptincancer
AT yiqianwang exploringthemetabolicsignalingnetworkofgfptincancer
AT jingliu exploringthemetabolicsignalingnetworkofgfptincancer
AT jinglv exploringthemetabolicsignalingnetworkofgfptincancer
AT tianxia exploringthemetabolicsignalingnetworkofgfptincancer
AT hailongpiao exploringthemetabolicsignalingnetworkofgfptincancer
AT yegangma exploringthemetabolicsignalingnetworkofgfptincancer